We thus showed for the first time that the percentages of CD8, PD-1, and PD-L1 expressing subpopulations of TILs differ in primary ovarian tumor tissues and metastatic intraperitoneal tumor implants. This evidence concerns the gene CD8A and ovarian neoplasm.